×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CORT – corcept therapeutics incorporated (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CORT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/2
04:42 am
cort
Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT
Medium
Report
Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT
2/2
04:41 am
cort
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
Medium
Report
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
2/2
03:33 am
cort
CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated
Low
Report
CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated
1/30
08:32 pm
cort
Hagens Berman Investigating Corcept Therapeutics (CORT): Shares Fall After Report That FDA Warned Against Relacorilant Drug Application Filing
Low
Report
Hagens Berman Investigating Corcept Therapeutics (CORT): Shares Fall After Report That FDA Warned Against Relacorilant Drug Application Filing
1/30
03:28 pm
cort
Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman
Low
Report
Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman
1/30
02:20 pm
cort
Berman Tabacco Announces Investigation of Corcept Therapeutics Incorporated (NASDAQ: CORT) Concerning FDA New Drug Application
Low
Report
Berman Tabacco Announces Investigation of Corcept Therapeutics Incorporated (NASDAQ: CORT) Concerning FDA New Drug Application
1/30
12:30 pm
cort
Rosen Law Firm Encourages Corcept Therapeutics Incorporated Investors to Inquire About Securities Class Action Investigation – CORT
Low
Report
Rosen Law Firm Encourages Corcept Therapeutics Incorporated Investors to Inquire About Securities Class Action Investigation – CORT
1/30
11:27 am
cort
CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated
Low
Report
CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated
Date
Time
Symbol
Company Name
Action
%Chg
11/4/2025
04:05 pm
cort
corcept therapeutics incorporated
MISS
Report
7.8%
corcept therapeutics incorporated
7/31/2025
04:05 pm
cort
corcept therapeutics incorporated
BEAT
Report
2.7%
corcept therapeutics incorporated
5/5/2025
04:05 pm
cort
corcept therapeutics incorporated
IN-LINE
Report
-1.8%
corcept therapeutics incorporated
2/26/2025
04:05 pm
cort
corcept therapeutics incorporated
MISS
Report
-5.6%
corcept therapeutics incorporated
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/29
04:10 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Jan 27 Filed by: BAKER G LEONARD JR
Low
Report
Form 4 CORCEPT THERAPEUTICS For: Jan 27 Filed by: BAKER G LEONARD JR
1/22
08:11 am
cort
Form 8-K CORCEPT THERAPEUTICS For: Jan 22
Medium
Report
Form 8-K CORCEPT THERAPEUTICS For: Jan 22
1/8
08:36 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Jan 06 Filed by: Guyer William
Low
Report
Form 4 CORCEPT THERAPEUTICS For: Jan 06 Filed by: Guyer William
1/6
12:04 pm
cort
Form 144 CORCEPT THERAPEUTICS Filed by: Guyer William
Low
Report
Form 144 CORCEPT THERAPEUTICS Filed by: Guyer William
1/5
06:11 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Jan 01 Filed by: BAKER G LEONARD JR
Low
Report
Form 4 CORCEPT THERAPEUTICS For: Jan 01 Filed by: BAKER G LEONARD JR
12/31
02:51 pm
cort
Form 8-K CORCEPT THERAPEUTICS For: Dec 31
Low
Report
Form 8-K CORCEPT THERAPEUTICS For: Dec 31
12/29
05:59 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Dec 24 Filed by: Robb Gary Charles
High
Report
Form 4 CORCEPT THERAPEUTICS For: Dec 24 Filed by: Robb Gary Charles
12/29
05:25 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Dec 24 Filed by: BELANOFF JOSEPH K
High
Report
Form 4 CORCEPT THERAPEUTICS For: Dec 24 Filed by: BELANOFF JOSEPH K
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/1
Q2/2019 6/30/2019 EPS 0.250 ZacksConsensus 0.180 ActVsEst 0.070 - Beat
14.1%
11/8 Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 9.1%
4/17 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.4%
2/28 Form 4 CORCEPT THERAPEUTICS For: Feb 26 Filed by: BELANOFF JOSEPH K 4.8%
3/13 Form 8-K CORCEPT THERAPEUTICS For: Mar 12 3.1%
9/24 Corcept Therapeutics Incorporated (NASDAQ: CORT) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating on the stock. 3.0%
5/14 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. 2.9%
11/7 Q3/2019 9/30/2019 EPS 0.310 ZacksConsensus 0.190 ActVsEst 0.120 - Beat 2.8%
5/23 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 2.7%
4/2 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 2.7%
11/8 Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 9.1%
4/17 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.4%
2/28 Form 4 CORCEPT THERAPEUTICS For: Feb 26 Filed by: BELANOFF JOSEPH K 4.8%
3/13 Form 8-K CORCEPT THERAPEUTICS For: Mar 12 3.1%
9/24 Corcept Therapeutics Incorporated (NASDAQ: CORT) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating on the stock. 3.0%
5/14 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. 2.9%
11/7 Q3/2019 9/30/2019 EPS 0.310 ZacksConsensus 0.190 ActVsEst 0.120 - Beat 2.8%
5/23 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 2.7%
4/2 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 2.7%
TOP News Decliners
3/5
Form 5 CORCEPT THERAPEUTICS For: Dec 31 Filed by: BAKER G LEONARD JR
-6.8%
3/13 Form 3 CORCEPT THERAPEUTICS For: Mar 12 Filed by: Alton Gregg H -6.4%
11/7 Corcept Therapeutics Incorporated (CORT) Q3 2019 Earnings Call Transcript [The Motley Fool] -5.4%
2/28 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.1%
5/9 Q1/2019 3/31/2019 EPS 0.200 ZacksConsensus 0.180 ActVsEst 0.020 - Beat -5.1%
1/30 Form 8-K CORCEPT THERAPEUTICS For: Jan 30 -4.6%
3/12 Corcept Therapeutics Appoints Gregg Alton to Board of Directors -4.4%
8/20 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at TheStreet from a "c+" rating to a "b" rating. -3.9%
4/27 Form DEF 14A CORCEPT THERAPEUTICS For: Apr 27 -3.5%
6/5 Form 4 CORCEPT THERAPEUTICS For: Jun 03 Filed by: BAKER G LEONARD JR -2.7%
3/13 Form 3 CORCEPT THERAPEUTICS For: Mar 12 Filed by: Alton Gregg H -6.4%
11/7 Corcept Therapeutics Incorporated (CORT) Q3 2019 Earnings Call Transcript [The Motley Fool] -5.4%
2/28 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.1%
5/9 Q1/2019 3/31/2019 EPS 0.200 ZacksConsensus 0.180 ActVsEst 0.020 - Beat -5.1%
1/30 Form 8-K CORCEPT THERAPEUTICS For: Jan 30 -4.6%
3/12 Corcept Therapeutics Appoints Gregg Alton to Board of Directors -4.4%
8/20 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at TheStreet from a "c+" rating to a "b" rating. -3.9%
4/27 Form DEF 14A CORCEPT THERAPEUTICS For: Apr 27 -3.5%
6/5 Form 4 CORCEPT THERAPEUTICS For: Jun 03 Filed by: BAKER G LEONARD JR -2.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: